ArticleJournal of lipid research2026
Malondialdehyde epitopes exposed on dying cells are potent modulators of complement activity and efferocytosis.
Article in Journal of lipid research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multicellular organisms rely on efficient removal of dying cells to maintain tissue homeostasis. However, during severe tissue damage, when clearance mechanisms are overwhelmed, uncleared dying cells expose various danger-associated molecular patterns (DAMPs), such as malondialdehyde (MDA)- epitopes, which further propagate disease-associated sterile inflammation. MDA-epitopes are present on the surface of dying cells and are specifically recognized by several complement proteins, but the precise nature of their membrane exposure nor whether, and how, this interaction contributes to the removal of dead cells is unknown. Here, we demonstrate that MDA-epitopes were detected on the surfaces of dying cells generated by extrinsic or intrinsic triggers of apoptosis, ferroptosis, and necroptosis, and their occurrence was associated with loss of membrane integrity. Moreover, we show that MDA adducts activate the classical complement pathway by directly binding natural IgM antibodies and C1q and regulate the extent of complement activation through MDA-dependent preferential recruitment of the acute-phase variant of C4b-binding protein (C4BP (α6β0)). This MDA-epitope-guided and C4BP-tuned opsonization of dying cells with IgM, C1q, C4b, and C3b modulates their clearance by phagocytes in human and murine in vitro assays. Our findings identify MDA-epitopes as key mediators in recognizing and clearing dying cells, linking oxidative stress to immune activation and tissue homeostasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.